Literature DB >> 277268

Immunotherapy of human acute leukemia: antibody response to leukemia-associated antigens.

M A Baker, J A Falk, R N Taub.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277268

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

2.  Complete remission in a patient with acute myelogenous leukemia treated with leukocyte alpha-interferon and cimetidine.

Authors:  J Ankerst; R Fäldt; P G Nilsson; P Flodgren; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Immunotherapy for remission maintenance in acute myeloblastic leukemia.

Authors:  M A Baker; R N Taub; W H Carter
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.

Authors:  D Urbanitz; T Büchner; H Pielken; J van de Loo
Journal:  Klin Wochenschr       Date:  1983-10-03

5.  Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells.

Authors:  M Pfreundschuh; B Dörken; W Brandeis; W Hunstein; P Wernet
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.

Authors:  R Fäldt; J Ankerst
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.